logo

Lyra Therapeutics Inc (LYRA) Stock: Navigating a Year of Stock Volatility

PNC Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Lyra Therapeutics Inc’s current trading price is -96.91% away from its 52-week high, while its distance from the 52-week low is 29.23%. The stock’s price range over this period has fluctuated between $0.16 and $6.79. The company, operating within the financial sector, had a trading volume of approximately 1.39 million for the day, which was noticeably lower than the average daily share volume of 1.83 million over the last 3 months.

Lyra Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $6.79 on 03/27/24 and the lowest value was $0.16 on 11/18/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Lyra Therapeutics Inc (LYRA) has experienced a quarterly decline of -20.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 13.74M and boasts a workforce of 88 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2156, with a change in price of -0.0710. Similarly, Lyra Therapeutics Inc recorded 1,553,425 in trading volume during the last 100 days, posting a change of -25.27%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for LYRA stands at 1.71. Similarly, the long-term debt-to-equity ratio is also 1.52.

LYRA Stock Stochastic Average

Today, Lyra Therapeutics Inc’s raw stochastic average for the past 50 days stands at 57.06%, indicating a decline from the raw stochastic average of the last 20 days, which was 79.91%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 76.00% and 68.08% respectively.

LYRA Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 1.74% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -29.98%. Over the past 30 days, the price of LYRA has fallen by 10.99%. And in the last five days, it has surged by 10.06%.

Most Popular